You are here

Multimodal Imaging Device for Real-time Assessment of Airway Tissue Viability and Compliance after Inhalation Injury

Award Information
Agency: Department of Defense
Branch: Defense Health Agency
Contract: W81XWH-17-C-0067
Agency Tracking Number: H16C-006-0029
Amount: $149,999.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: DHP16C-006
Solicitation Number: 2016.0
Timeline
Solicitation Year: 2017
Award Year: 2017
Award Start Date (Proposal Award Date): 2017-05-15
Award End Date (Contract End Date): 2017-11-14
Small Business Information
20 New England Business Center
Andover, MA 01810
United States
DUNS: 073800062
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Nicusor Iftimia
 (978) 689-0003
 iftimia@psicorp.com
Business Contact
 B. David Green
Phone: (978) 689-0003
Email: green@psicorp.com
Research Institution
 University of North Carolina
 Terry Magnuson
 
Campus Box 7513
Chapel Hill, NC 27599
United States

 (919) 966-3411
 Nonprofit College or University
Abstract

Inhalation injury is an important cause of morbidity and mortality in both military personnel and the civilian population. Bronchoscopy, currently the gold standard for assessment of inhalation injury, fails to provide submucosal and functional tissue information, both of which are essential for improved prognostic information. Physical Sciences Inc., in collaboration with University of North Carolina, Chapel Hill, proposes to develop a novel multimodal imaging instrument that will provide clinicians with real-time feedback regarding the morphological appearance of the injured tissue, as well as functional data such as compliance, ciliary activity, vasodilation and blood flow. This instrument will complement qualitative bronchoscopic findings and will permit more efficient screening, triage, and therapeutic guidance of inhalation exposures.The Phase I study will determine the feasibility of the proposed technology for epithelial airway inhalation injury assessment. In Phase II, an advanced, highly engineered and rugged instrument is proposed to be developed and evaluated on patients with inhalation injuries. A Phase III continuation program is planned as well with the goal of further improving this technology and making it suitable for use in role 2 military settings and for the civilian market, as well as for getting FDA approval for commercialization.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government